14-93939148-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000555019.6(ASB2):āc.1577A>Gā(p.Asn526Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,573,786 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000555019.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB2 | NM_001202429.2 | c.1577A>G | p.Asn526Ser | missense_variant | 8/10 | ENST00000555019.6 | NP_001189358.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB2 | ENST00000555019.6 | c.1577A>G | p.Asn526Ser | missense_variant | 8/10 | 1 | NM_001202429.2 | ENSP00000451575.1 | ||
ASB2 | ENST00000315988.8 | c.1433A>G | p.Asn478Ser | missense_variant | 6/8 | 1 | ENSP00000320675.4 | |||
ASB2 | ENST00000555507.5 | c.1271A>G | p.Asn424Ser | missense_variant | 6/7 | 5 | ENSP00000450940.1 | |||
ASB2 | ENST00000553883.1 | n.1348A>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000174 AC: 36AN: 207112Hom.: 0 AF XY: 0.000236 AC XY: 27AN XY: 114358
GnomAD4 exome AF: 0.000155 AC: 221AN: 1421622Hom.: 1 Cov.: 31 AF XY: 0.000180 AC XY: 126AN XY: 701560
GnomAD4 genome AF: 0.000118 AC: 18AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74334
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at